TipRanks
TipRanksTop Financial ExpertsInsidersCameron Turtle

Cameron Turtle Insider Profile

4 Followers
Cameron Turtle, CEO, Director at Spyre Therapeutics, holds 552.54K shares in Spyre Therapeutics (Ticker: SYRE), holds ― shares in Oruka Therapeutics (Ticker: ORKA), holds ― shares in Damora Therapeutics (Ticker: DMRA).
See the Hottest Stocks Based on Insider Trading >
tipranks
Cameron Turtle

Cameron Turtle
Spyre Therapeutics (SYRE)
CEO, Director

Ranked #101,204 out of 109,232 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-57.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$45M
98.13%
1.87%
0.00%
0.00%
A breakdown of Cameron Turtle's holdings
See the Top Stocks by Insiders

Insider Roles

Spyre Therapeutics
(SYRE)
CEO, Director
BridgeBio Pharma
(BBIO)
SVP, Portfolio Management and Corporate Developmen
Oruka Therapeutics
(ORKA)
Director
Damora Therapeutics
(DMRA)
Director
Roles that Cameron Turtle holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Eidos Therapeutics
(EIDX)
Rating:Informative Sell
Date:Sep 06, 2019 - Sep 06, 2020
Return:+2.10%
The most profitable trade made by Cameron Turtle
See the Latest Stocks Traded by Insiders

Cameron Turtle's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SYRE
Spyre Therapeutics
Sep 03, 2026
CEO, Director
Uninformative Sell
1.31M
$44.26M
ORKA
Oruka Therapeutics
―
Director
―
―
DMRA
Damora Therapeutics
―
Director
―
―
EIDX
Eidos Therapeutics
Nov 13, 2020
―
Uninformative Sell
―
$6.19M
BBIO
BridgeBio Pharma
Dec 29, 2020
SVP, Portfolio Management and Corporate Developmen
Uninformative Buy
130.50K
$841.55K
List of latest transactions for each holding click on a transaction to see Cameron Turtle's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Cameron Turtle insider profile FAQ

What is the percentage of profitable transactions made by Cameron Turtle?
The percentage of profitable transactions made by Cameron Turtle is 25%.
    What is the average return per transaction made by Cameron Turtle?
    The average return per transaction made by Cameron Turtle is -57.20%.
      What stocks does Cameron Turtle hold?
      Cameron Turtle holds: SYRE, ORKA, DMRA, EIDX, BBIO stocks.
        What was Cameron Turtle’s latest transaction?
        Cameron Turtle latest transaction was an Uninformative Sell of $1.31M.
          What was Cameron Turtle's most profitable transaction?
          Cameron Turtle’s most profitable transaction was an Informative Sell of EIDX stock on September 6, 2019. The return on the trade was 2.10%.
            What is Cameron Turtle's role in Spyre Therapeutics?
            Cameron Turtle's role in Spyre Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.